Daiwa Securities Group Inc. Decreases Position in HCA Healthcare, Inc. $HCA

10 Dec 2025, 05:40 by Scott Moore · The Cerbat Gem

Daiwa Securities Group Inc. reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,469 shares of the company’s stock after selling 2,143 shares during the quarter. Daiwa Securities Group Inc.’s holdings in HCA Healthcare were worth $14,738,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Saudi Central Bank bought a new position in shares of HCA Healthcare in the first quarter worth approximately $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare in the 1st quarter worth $27,000. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare during the second quarter valued at about $27,000. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the second quarter worth about $27,000. Finally, Clearstead Trust LLC lifted its holdings in HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts recently commented on the company. UBS Group raised their price target on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Bank of America lifted their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research note on Monday, October 27th. TD Cowen increased their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Wells Fargo & Company upped their target price on HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a report on Thursday, November 13th. Finally, Raymond James Financial set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $474.53.

Read Our Latest Research Report on HCA

HCA Healthcare Stock Up 0.7%

HCA Healthcare stock opened at $488.44 on Wednesday. The stock’s 50 day moving average is $462.50 and its 200 day moving average is $411.98. The company has a market capitalization of $111.46 billion, a P/E ratio of 18.88, a PEG ratio of 1.43 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

About HCA Healthcare

(Free Report)